HSDT
Solana Company Class A Common Stock (DE)
stockNASDAQ
helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.84 | 2026-09-28 | -7.39% | 4.856 |
| 1M | 2.24 | 2026-09-04 | +17.41% | 4.245 |
| 3M | 1.82 | 2026-07-06 | +44.51% | 2.854 |
| 6M | 1.90 | 2026-04-06 | +38.42% | 2.701 |
| 1Y | 18.19 | 2025-10-06 | -85.54% | 3.183 |
| 2Y | 412.50 | 2024-10-04 | -99.36% | — |
| 5Y | 505,428.75 | 2021-10-06 | -100.00% | 1.387 |
Solana Company Class A Common Stock (DE) (NASDAQ:HSDT) stock price today is $2.63, and today's volume is 482,249. HSDT is up 0.382% today. The 30 day average volume is 547,620. HSDT market cap is $171.23M with 65.10M shares outstanding.